Evaluating electronic cigarette cytotoxicity and inflammatory responses in vitro

Area of Science:

• Toxicology
• Cell Biology
• Pulmonary Medicine

Background:

• Cigarette smoking causes severe health issues like COPD and cancer.
• Nicotine addiction hinders smoking cessation.
• Electronic cigarettes (e-cigarettes) may reduce exposure to toxic chemicals but can still be harmful, especially for dual users.

Purpose of the Study:

• To develop bioassays for assessing toxicity and inflammatory responses to e-cigarette liquids (e-liquids).
• To evaluate the impact of varying nicotine levels and flavors in e-liquids on human cells in vitro.

Main Methods:

• Human bronchial epithelial cells (BEAS-2B) and monocyte-macrophage cells (THP-1) were exposed to aerosolized e-liquids in vitro.
• Cytotoxicity was measured using MTT assay.
• Inflammatory markers (TNF-α, IL-6, IL-8, MCP-1), oxidative stress (REDD1), and phagocytosis were assessed.

Main Results:

• E-cigarette aerosols induced moderate cellular toxicity in bronchial epithelial cells.
• Lower nicotine concentrations demonstrated less damage to bronchial epithelial cells.
• Flavors in e-liquids influenced inflammatory markers, phagocytosis, and REDD1 levels.

Conclusions:

• Developed in vitro bioassays effectively measure e-cigarette effects.
• These assays can quantify flavor and nicotine-induced cytotoxicity and inflammation in human cells.